Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$11.11 USD
+0.08 (0.73%)
Updated Aug 8, 2024 11:54 AM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Green Thumb Industries Inc. (GTBIF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.25 | $34.75 | $13.00 | 92.66% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Green Thumb Industries Inc. comes to $21.25. The forecasts range from a low of $13.00 to a high of $34.75. The average price target represents an increase of 92.66% from the last closing price of $11.03.
Analyst Price Targets (11)
Broker Rating
Green Thumb Industries Inc. currently has an average brokerage recommendation (ABR) of 1.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.18 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, nine are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 81.82% and 18.18% of all recommendations. A month ago, Strong Buy made up 81.82%, while Buy represented 18.18%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 8 | 9 | 10 | 11 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.18 | 1.20 | 1.18 | 1.17 | 1.15 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | Cormark Securities | Jesse Pytlak | Moderate Buy | Moderate Buy |
8/6/2024 | Haywood Securities | Neal Gilmer | Strong Buy | Strong Buy |
8/6/2024 | The Benchmark Company | Michael J Hickey | Strong Buy | Strong Buy |
8/6/2024 | PI Financial Corp. | Andrew Semple | Not Available | Strong Buy |
7/23/2024 | Seaport Research Partners | Sonny Randhawa | Strong Buy | Strong Buy |
7/3/2024 | ATB Capital Markets | Frederico Gomes | Strong Buy | Strong Buy |
5/9/2024 | Roth Capital Partners | Scott Fortune | Strong Buy | Strong Buy |
5/9/2024 | Needham & Company | Matthew R Mcginley | Moderate Buy | Moderate Buy |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/1/2024 | Canaccord Genuity | Matt Bottomley | Not Available | Strong Buy |
2/29/2024 | Alliance Global Partners | Aaron Grey | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.18 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 11 |
Average Target Price | $21.25 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | 0.06 |